Publicidad

Desarrollo y evaluación de un ligando flexible para la preparación de radiofármacos de 99mTc

Referencias

  1. Decristoforo C, Santos I, Pietzsch HJ, Duatti A, Smith CJ, Rey A, et al. Comparison of in vitro and in vivo properties of 99mTc-cRGD peptides labelled using different novel Tc-cores. Q J Nucl Med Mol Imaging 2007;51:33-41.
  2. Labelling of small biomolecules using novel Technetium-99m cores. IAEA Technical Report Series 458, IAEA, Vienna, 2007. (http://www-pub.iaea.org/MTCD/publications/PDF/trs459_web.pdf).
  3. Spies H, Glaser M, Pietzsch H-J, Hahn FE, Lügger T. Synthesis and reactions of trigonal-bipyramidal rhenium and technetium complexes with tripodal, tetradentate NS3 ligand. Inorg Chim 1995;Acta 240:465-78.
  4. Pietzsch H-J, Gupta A, Syhre R, Leibnitz P, Spies H. Mixed-ligand technetium(III) complexes with tetradentate/monodentate NS3/isocyanide coordination: A new nonpolar technetium chelate system for the design of neutral and lipophilic complexes stable in vivo. Bioconj Chem 2001;12:538-44.
  5. Alberto R, Schibli R, Waibel A, et al. Basic aqueous chemistry of [M(OH2)3(CO)3]+ (M=Re, Tc) directed towards radiopharmaceutical application. Coord Chem Rev 1999;190:901-19.
  6. Mundwiler S, Kundig M, Ortner K, et al. A new [2+1] mixed ligand concept based on [99(m)Tc(OH2)3(CO)3]+: a basic study. Dalton Trans 2004;7:1320-8.
  7. Giglio J, Fernández S, Cerecetto H, Rey A. Synthesis and biological characterization of novel dithiocarbamate containing 5-nitroimidazole 99mTc-complexes as potential agents for targeting hypoxia. Bioorg Med Chem Letters 2011;21:394-7.